0001144204-18-056564.txt : 20181031 0001144204-18-056564.hdr.sgml : 20181031 20181031192401 ACCESSION NUMBER: 0001144204-18-056564 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180924 FILED AS OF DATE: 20181031 DATE AS OF CHANGE: 20181031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wealth Strategy Holding Ltd CENTRAL INDEX KEY: 0001723544 STATE OF INCORPORATION: K3 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 181151531 BUSINESS ADDRESS: STREET 1: LEVEL 12, INTERNATIONAL COMMERCE CENTRE STREET 2: 1 AUSTIN ROAD WEST CITY: HONG KONG STATE: K3 ZIP: HK BUSINESS PHONE: 36698324 MAIL ADDRESS: STREET 1: LEVEL 12, INTERNATIONAL COMMERCE CENTRE STREET 2: 1 AUSTIN ROAD WEST CITY: HONG KONG STATE: K3 ZIP: HK ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 3 1 tv506010_3.xml OWNERSHIP DOCUMENT X0206 3 2018-09-24 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001723544 Wealth Strategy Holding Ltd LEVEL 12 INTERNATIONAL COMMERCE CENTRE 1 AUSTIN ROAD WEST HONG KONG K3 HK HONG KONG 0 0 1 0 Common Stock 8594061 D Warrant 1.69 2017-01-23 2020-01-23 Common Stock 493827 D Warrant 3.75 2018-04-17 2020-04-17 Common Stock 666666 D Warrant 3.69 2018-09-17 2023-03-21 Common Stock 370370 D Warrant 7.19 2019-03-23 2021-09-24 Common Stock 559701 D /s/ Ken Tsang, Compliance Officer, on behalf of Wealth Strategy Holding Limited 2018-10-25